Yang, Xiuqiao
Lin, Hong
Liu, Shuning
Ai, Chunyan
Cai, Zhanghong
Yu, Rong
Xu, Xiaoyi
Gao, Jinghong
Chen, Yuwen
Wen, Ping
Funding for this research was provided by:
Liaoning Pharmaceutical Industry Innovation and Development Strategy Research and Funding Project (NO. 2020lslktyb-095)
National Medical Products Administration - Special Fund of Drug Regulatory Research Institute of Shenyang Pharmaceutical University (NO. 2021jgkx004)
Shenzhen Health Economics Society Research Fund Project (NO.202333)
Shenzhen Maternity & Child Healthcare Hospital Science Foundation (NO. 2022 (73))
Article History
Received: 14 September 2024
Accepted: 16 September 2025
First Online: 14 November 2025
Declarations
:
: Approval was obtained from the Ethic Committee of Shenzhen Maternity & Child Healthcare Hospital, protocol number SFYLS[2022]030. Data were collected via an online questionnaire distributed to domain experts. Invited experts who proceeded to complete and submit the questionnaire were considered to have provided informed consent.
: Not applicable.
: The authors declare no competing interests.